← Open Payments lookup

EMILY MOORE: Open Payments

NPI 1730579921 · ARKADELPHIA, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$481 in 30 payments from 8 companies in 2025. Trend: 2023 $595 · 2024 $446 · 2025 $481

Food & beverage: $481
CompanyPaymentsAmount
Lilly USA, LLC13$135
Dexcom, Inc.5$99
AstraZeneca Pharmaceuticals LP4$70
Abbott Laboratories3$54
ABBVIE INC.2$45
ABIOMED1$39
Otsuka America Pharmaceutical, Inc.1$25
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$15

Products named: Dexcom G6 Transmitter, JARDIANCE, MOUNJARO, FREESTYLE LIBRE 3, BREZTRI, FARXIGA, UBRELVY, REXULTI.

Industry payments across AR — which companies pay providers there.